I  have  experienced  numerous  successes  in  helping  clients  recover  as  individual  plaintiffs,  claimants  and  as  litigants  involved  in  prior  and  current  matters  such  as:  

• In  re:  Prempro  Products  Product  Liability  Litigation,  MDL  1507,  alleged  that  use  of  hormone  replacement  therapy  drugs,  such  as  Prempro,  drugs  caused  breast  cancer.    

• In  re:  Accutane  Products  Liability,  MDL  1626,  use  alleged  to  have  resulted  in  bowel  disease,  such  as  Ulcerative  Colitis  or  Crohn’s  Disease.    

• In  re  Mirapex  Product  Liability  Litigation,  MDL  1836,  alleged  use  caused  pathological  gambling  and  other  compulsive  behaviors.    

• In  re  Chantix  (Varenicline)  Products  Liability  Litigation,  MDL  2092,  alleged  use  resulted  in  a  wide-­‐variety  of  side  effects  and  risks,  including  behavioral  changes,  depression,  aggression,  agitation,  hostility,  rage,  suicidal  ideation,  suicide  attempts,  and  suicide.    

• In  re:  Zicam  Cold  Remedy  Marketing,  Sales  Practices  and  Products  Liability  Litigation,  MDL  2096,  alleged  that  use  of  Zicam  nasal  cold  remedy  products  caused  anosmia  (the  loss  of  sense  of  smell).    

• In  re  Yasmin  and  YAZ  (Drospirenone)  Marketing,  Sales  Practices  and  Products  Liability  Litigation,  MDL  2100,  alleged  use  resulted  in  various  serious  side  effects,  including  deep  vein  thrombosis  (DVT),  pulmonary  embolism  (PE),  and  ischemic  stroke  (CVA).    

• In  re:  Zimmer  Durom  Hip  Cup  Products  Liability  Litigation,  MDL  2158,  complications  alleged  to  have  resulted  from  devices  include  premature  implant  loosening,  metallosis,  tissue  damage,  premature  failure,  and  the  need  for  early  revision  surgery.    

• In  re:  DePuy  Orthopaedics,  Inc.,  ASR  Hip  Implant  Products  Liability  Litigation,  MDL  2197,  complications  alleged  to  have  resulted  from  devices  include  multiple  revision  surgery  and  complications  such  as  stroke,  pulmonary  embolism,  deep-­‐vein  thrombosis,  hip  dislocation  and  foot  drop  (abnormal  gait).    

• In  re:  Actos  (Pioglitazone)  Products  Liability  Litigation,  MDL  2299,  alleged  that  individuals  who  use  Actos  face  an  increased  risk  of  developing  bladder  cancer.    

• In  Re:  Skechers  Toning  Shoe  Products  Liability  Litigation,  MDL  2308,  products  are  alleged  to  have  caused  serious  injuries,  including  broken  feet  and  ankles,  leg  and  hip  fractures,  tendon  and  ligament  damage,  head  injuries,  and  spinal  cord  damage.  

• In  Re:  National  Football  League  Players’  Concussion  Injury  Litigation,  MDL  2323,  former  NFL  players  allege  to  have  sustained  head  trauma  resulting  in  long-­‐term  cognitive  health  problems  while  playing  for  the  NFL  and  accuse  the  League  of  failing  to  inform  them  of  the  risks  linked  to  concussions  and  neglecting  to  minimize  brain  injury  risks  to  protect  their  short  and  long-­‐term  cognitive  health.    

• In  Re:  Mirena  IUD  Products  Liability  Litigation,  MDL  2434  alleged  that  use  led  to  uterine  and  internal  organ  perforation.    

• In  Re:  Incretin  Based  Therapies  Products  Liability  Litigation,  MDL  2452,  plaintiffs  allege  that  the  use  of  one  or  more  of  four  anti-­‐diabetic  incretin  based  medications  –  Janumet  (sitagliptin  combined  with  metformin),  Januvia  (sitagliptin),  Byetta  (exenatide)  and  Victoza  (liraglutide)  –  caused  them  or  their  decedent  to  develop  pancreatic  cancer.    

• Individual  plaintiff  actions  against  Medtronic  related  to  the  use  of  the  Medtronic  Infuse  Bone  Growth,  or  Infuse  BMP  alleging  risks  such  as:  unwanted  bone  growth  (ectopic  bone  growth),  inflammatory  reactions,  adverse  back  and  leg  pain  events,  radiculitis,  retrograde  ejaculation  in  men,  urinary  retention,  bone  resorption,  and  implant  displacement.